# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001178913-23-001067
Filing Date
2023-03-21
Accepted
2023-03-21 06:02:01
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-03-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | zk2329416.pdf | ARS | 2883208
| Complete submission text file | 0001178913-23-001067.txt |  | 3919220

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38807 | Film No.: 23747764
SIC: 2834 Pharmaceutical Preparations